Bennett, C. L., Dastidar, S., Arnold, F. J., McKinstry, S. U., Stockford, C., Freibaum, B. D., . . . La Spada, A. R. (2023). Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity. Acta Neuropathologica Communications, 11(1), 1. https://doi.org/10.1186/s40478-023-01665-z
Chicago Style (17th ed.) CitationBennett, Craig L., et al. "Senataxin Helicase, the Causal Gene Defect in ALS4, Is a Significant Modifier of C9orf72 ALS G4C2 and Arginine-containing Dipeptide Repeat Toxicity." Acta Neuropathologica Communications 11, no. 1 (2023): 1. https://doi.org/10.1186/s40478-023-01665-z.
MLA (9th ed.) CitationBennett, Craig L., et al. "Senataxin Helicase, the Causal Gene Defect in ALS4, Is a Significant Modifier of C9orf72 ALS G4C2 and Arginine-containing Dipeptide Repeat Toxicity." Acta Neuropathologica Communications, vol. 11, no. 1, 2023, p. 1, https://doi.org/10.1186/s40478-023-01665-z.